A

Associated Medical Professionals of NY, PLLC | Syracuse, NY

Research site
(Unclaimed)
Location
1226 East Water Street, Syracuse, New York, United States of America
Site insights

Top conditions

Prostatic Cancer (11 trials)

Non-Muscle Invasive Bladder Cancer (1 trial)

Hypersensitivity (1 trial)

Urinary Bladder Cancer (1 trial)

Carcinoma (1 trial)

Top treatments

Darolutamide
Relugolix
Androgen
Bicalutamide
UGN-102
valacyclovir
VERU-111
Leuprolide Acetate
TAS3681

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 13
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP)

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means that in men who had p...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in pa...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Drug: Darolutamide (BAY1841788, Nubeqa)
Other: ADT

The purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with interm...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostat...

Active, not recruiting
Prostate Cancer
Biological: placebo
Biological: aglatimagene besadenovec

This is a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. This st...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: TAS3681

The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and...

Enrolling
Cancer
Drug: Darolutamide (Nubeqa, BAY1841788)

Trial sponsors

Bayer logo

Bayer (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems